Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up
Joint Authors
Post, Martijn C.
Snijder, R. J. R.
Renes, L. E.
Bosshardt, D.
Suttorp, M. J.
ten Berg, J. M.
Source
Journal of Interventional Cardiology
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-02-14
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Purpose.
The Occlutech Figulla occluder has been proven safe and effective at midterm follow-up after percutaneous atrial septal defect (ASD) closure.
We describe the safety and efficacy at long-term follow-up in adults.
Methods.
All consecutive adult patients that underwent ASD closure between 2008 and 2015 were included.
All complications were registered.
Residual left-to-right shunt (LRS) was diagnosed using color-Doppler transthoracic echocardiography (TTE).
Right-to-left shunting was diagnosed using contrast TTE.
Successful closure was defined as no LRS at follow-up.
Results.
In total, 166 patients (mean age 56.7 ± 16.1 years; 62% female) underwent percutaneous ASD closure using the Occlutech Flex I (70%) or Flex II (30%) device (diameter 24 mm; range 10–40 mm) under general anaesthesia and transoesophageal echocardiographic guidance.
Long-term follow-up data were available for 144 patients (87%) with a mean follow-up of 5.9 ± 2.6 years, a total of 814 patient-years.
During hospitalization, device embolization occurred in three patients (1.8%) with successful extraction in all.
During the long-term follow-up, 15 patients (9.8%) suffered new-onset atrial fibrillation and stroke occurred in 2.1%.
There was no residual LRS at 12-month follow-up.
No device embolization occurred during the long-term follow-up.
Conclusion.
Percutaneous ASD closure using the Occlutech device appears to be safe at long-term follow-up with a high successful closure rate at one year.
American Psychological Association (APA)
Snijder, R. J. R.& Renes, L. E.& Bosshardt, D.& Suttorp, M. J.& ten Berg, J. M.& Post, Martijn C.. 2020. Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up. Journal of Interventional Cardiology،Vol. 2020, no. 2020, pp.1-5.
https://search.emarefa.net/detail/BIM-1187849
Modern Language Association (MLA)
Snijder, R. J. R.…[et al.]. Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up. Journal of Interventional Cardiology No. 2020 (2020), pp.1-5.
https://search.emarefa.net/detail/BIM-1187849
American Medical Association (AMA)
Snijder, R. J. R.& Renes, L. E.& Bosshardt, D.& Suttorp, M. J.& ten Berg, J. M.& Post, Martijn C.. Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up. Journal of Interventional Cardiology. 2020. Vol. 2020, no. 2020, pp.1-5.
https://search.emarefa.net/detail/BIM-1187849
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1187849